Pennsylvania 2025-2026 Regular Session

Pennsylvania House Bill HB1301 Latest Draft

Bill / Introduced Version

                             
PRINTER'S NO. 1495 
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE BILL 
No.1301 
Session of 
2025 
INTRODUCED BY KHAN, KENYATTA, KOSIEROWSKI, KRAJEWSKI, SCOTT, 
GIRAL, SANCHEZ, GUENST, HANBIDGE, PIELLI, MALAGARI, MAYES, 
HOHENSTEIN, CEPEDA-FREYTIZ, STEELE, HILL-EVANS, OTTEN, GREEN, 
DALEY, BOROWSKI AND CARROLL, APRIL 28, 2025 
REFERRED TO COMMITTEE ON HEALTH, APRIL 28, 2025 
AN ACT
Requiring health insurance policies to provide coverage for pre-
exposure prophylaxis and post-exposure prophylaxis HIV 
medication and associated laboratory tests and patient 
visits.
The General Assembly of the Commonwealth of Pennsylvania 
hereby enacts as follows:
Section 1.  Short title.
This act shall be known and may be cited as the PrEP and PEP 
for Pennsylvania Act.
Section 2.  Definitions.
The following words and phrases when used in this act shall 
have the meanings given to them in this section unless the 
context clearly indicates otherwise:
"Health care provider."  A licensed hospital or health care 
facility or a person licensed, certified or otherwise regulated 
to provide health care services under the laws of this 
Commonwealth, including a physician, psychologist, emergency 
medical services worker, advanced practice registered nurse or 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18 physician's assistant.
"Health insurance policy."  As follows:
(1)  An individual or group health insurance policy, 
contract or plan that provides medical or health care 
coverage by a health care provider on an expense-incurred 
service or prepaid basis that is offered by or is governed 
under any of the following:
(i)  The act of May 17, 1921 (P.L.682, No.284), known 
as The Insurance Company Law of 1921, including section 
630 of that act.
(ii)  The act of December 29, 1972 (P.L.1701, 
No.364), known as the Health Maintenance Organization 
Act.
(iii)  40 Pa.C.S. Ch. 61 (relating to hospital plan 
corporations) or 63 (relating to professional health 
services plan corporations).
(2)  The term does not include accident only, fixed 
indemnity, hospital indemnity, limited benefit, credit, 
dental, vision, specified disease, Medicare supplement, long-
term care, disability income, workers' compensation, 
automobile medical payment insurance or a policy under which 
benefits are provided by the Federal Government to active or 
former military personnel and their dependents.
"HIV."  The human immunodeficiency virus.
"PEP."  A post-exposure prophylaxis HIV medication that is 
approved by the United States Food and Drug Administration and 
that can be taken as a prophylaxis to prevent the transmission 
of the human immunodeficiency virus after a person is exposed.
"PrEP."  A pre-exposure prophylaxis HIV medication that is 
approved by the United States Food and Drug Administration and 
20250HB1301PN1495 	- 2 - 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30 that can be taken as a prophylaxis to prevent the transmission 
of the human immunodeficiency virus before a person is exposed.
"Prescriber."  A person licensed, registered or otherwise 
lawfully authorized to distribute, dispense or administer 
medication.
Section 3.  Mandated coverage.
(a)  Requirements.--
(1)  A health insurance policy that is offered, issued or 
renewed in this Commonwealth on or after the effective date 
of this subsection shall provide coverage for all the 
expenses associated with PEP and PrEP, including the costs of 
associated laboratory tests, patient visits to a health care 
provider for the purpose of HIV medication counseling and 
patient visits to a prescriber to have PEP and PrEP 
prescribed or maintained.
(2)  A patient shall not incur any copay, coinsurance, 
deductible or other costsharing for any of the expenses 
associated with PEP and PrEP, including the costs of 
associated laboratory tests, patient visits to a health care 
provider for the purpose of HIV medication counseling and 
patient visits to a prescriber to have PEP or PrEP prescribed 
or maintained.
(b)  Specialty tier.--A provider of a health insurance policy 
may not move a PEP or PrEP, or an associated laboratory service 
for monitoring, visit to a health care provider or visit to a 
prescriber, into a specialty tier solely for monetary gain.
(c)  Counseling.--Unless medically necessary, a health 
insurance policy shall not require counseling by an infectious 
disease specialist or immunologist as a condition to receive PEP 
or PrEP, or an associated laboratory service for monitoring, 
20250HB1301PN1495 	- 3 - 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30 visit to a health care provider or visit to a prescriber.
Section 4.  Applicability.
This act shall apply as follows:
(1)  For health insurance policies for which either rates 
or forms are required to be filed with the Federal Government 
or the Insurance Department, this act shall apply to any 
policy for which a form or rate is first filed on or after 
the effective date of this paragraph.
(2)  For health insurance policies for which neither 
rates nor forms are required to be filed with the Federal 
Government or the Insurance Department, this act shall apply 
to any policy issued or renewed on or after 180 days after 
the effective date of this paragraph.
Section 5.  Effective date.
This act shall take effect in 60 days.
20250HB1301PN1495 	- 4 - 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15